News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PIMSTONE SIMON N.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,475 options to buy
@ $38.96, valued at
$719.8k
|
|
| 06/01/2023 |
4
| PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Sold 18,006 shares
@ $38.63, valued at
$695.6k
Sold 19,000 shares
@ $39.9, valued at
$758.1k
Sold 12,000 shares
@ $38.53, valued at
$462.4k
Exercised 29,835 shares
@ $9.85, valued at
$293.9k
Paid exercise price by delivering 6,165 shares
@ $38.37, valued at
$236.6k
Sold 23,670 shares
@ $38.81, valued at
$918.6k
Paid exercise price by delivering 23,144 shares
@ $38.37, valued at
$888k
Sold 26,856 shares
@ $38.69, valued at
$1M
Paid exercise price by delivering 1,860 shares
@ $38.53, valued at
$71.7k
Sold 7,458 shares
@ $38.97, valued at
$290.6k
Paid exercise price by delivering 20,745 shares
@ $38.53, valued at
$799.3k
|
|
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/09/2023 |
4
| PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Exercised 41,152 shares
@ $2.68, valued at
$110.3k
Paid exercise price by delivering 2,160 shares
@ $37.13, valued at
$80.2k
Sold 10,990 shares
@ $37.01, valued at
$406.7k
Exercised 30,864 shares
@ $2.59, valued at
$79.9k
Paid exercise price by delivering 1,618 shares
@ $37.13, valued at
$60.1k
Sold 8,242 shares
@ $36.94, valued at
$304.5k
Exercised 41,152 options to buy
@ $0
Exercised 30,864 options to buy
@ $0 |
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2021 |
4
| PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Sold 17,557 shares
@ $31.33, valued at
$550.1k
|
|
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Disposed of 45,000 shares
@ $0 |
|
| 06/02/2020 |
4
| PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Sold 5,000 shares
@ $13.99, valued at
$70k
Sold 3,000 shares
@ $14.43, valued at
$43.3k
|
|
| 05/28/2020 |
4
| PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Exercised 6,172 shares
@ $3.56, valued at
$22k
Paid exercise price by delivering 1,108 shares
@ $14.9, valued at
$16.5k
Exercised 6,172 options to buy
@ $0 |
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2019 |
4
| PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Sold 10,395 shares
@ $9.51, valued at
$98.9k
|
|
| 09/18/2019 |
4
| PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Exercised 36,008 shares
@ $3.7, valued at
$133.2k
Paid exercise price by delivering 10,769 shares
@ $9.44, valued at
$101.7k
Exercised 9,259 shares
@ $3.07, valued at
$28.4k
Paid exercise price by delivering 2,769 shares
@ $9.44, valued at
$26.1k
Exercised 12,345 shares
@ $3.38, valued at
$41.7k
Paid exercise price by delivering 3,692 shares
@ $9.44, valued at
$34.9k
Granted 280,000 options to buy
@ $9.44, valued at
$2.6M
Exercised 36,008 options to buy
@ $0
Exercised 9,259 options to buy
@ $0
Exercised 12,345 options to buy
@ $0 |
|
| 03/14/2018 |
4
| PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Exercised 10,288 shares
@ $3.77, valued at
$38.8k
Exercised 10,288 options to buy
@ $0 |
|
| 03/13/2018 |
4
| PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 140,000 options to buy
@ $4.75, valued at
$665k
|
|
| 10/24/2017 |
4
| PIMSTONE SIMON N. (President & CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 11,000 options to buy
@ $3.1, valued at
$34.1k
|
|
| 08/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/02/2016 |
4
| PIMSTONE SIMON N. (President & CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Exercised 12,345 shares
@ $3.3, valued at
$40.7k
Paid exercise price by delivering 4,703 shares
@ $7.46, valued at
$35.1k
Exercised 12,345 options to buy
@ $0 |
|
| 03/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|